Exousia Pro, Inc. (MAJI)
OTCMKTS · Delayed Price · Currency is USD
0.0450
-0.0030 (-6.25%)
Feb 11, 2026, 1:34 PM EST
Exousia Pro Market Cap
Exousia Pro has a market cap or net worth of $1.96 million as of February 12, 2026. Its market cap has increased by 6.63% in one year.
Market Cap
1.96M
Enterprise Value
2.67M
Revenue
-12.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since May 2, 2011, Exousia Pro's market cap has decreased from 21.45M to 1.96M, a decrease of -90.84%. That is a compound annual growth rate of -14.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 1.98M | -12.24% |
| Dec 31, 2025 | 2.25M | 16.97% |
| Dec 31, 2024 | 1.93M | -50.14% |
| Dec 28, 2023 | 3.86M | 225.30% |
| Dec 30, 2022 | 1.19M | -58.10% |
| Dec 31, 2021 | 2.83M | -84.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neon Bloom | 1.85M |
| Agentix | 1.68M |
| Galera Therapeutics | 1.66M |
| Carisma Therapeutics | 1.65M |
| ZyVersa Therapeutics | 1.62M |
| inTerra Resources | 1.49M |
| International Stem Cell | 1.32M |
| Sigyn Therapeutics | 1.20M |